300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Email
Payments
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Hospitality
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Fashion
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Social
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Beauty
Enterprise
Community
Media (Entertainment)
Infrastructure
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Taiwan
Liberia
Mexico
Nigeria
Tunisia
Russian Federation
Togo
Guinea
Nepal
Sweden
Iran
Isle of Man
Madagascar
Pakistan
Zimbabwe
Zambia
Norway
Romania
Tajikistan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Malawi
Venezuela
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Canada
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
United Kingdom
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
b.value AG, VC Fund

b.value AG

VC Fund

Dortmund, Germany

b.value AG is a VC fund in Dortmund focused on Biotechnology and Manufacturing. b.value AG are into Biotechnology investments.

Total investments:
14
Last investment:
Lead investor:
14%

Last updated:

Industries b.value AG invests in

BiotechnologyManufacturingChemicalHealth CareLife Science

Stages b.value AG invests in

SeedSeries AFunding RoundPre-SeedVenture - Series Unknown

Countries b.value AG invests in

GermanyPoland

Round sizes

Seed $541k–$2.5MSeries A $3M–$39M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Round size

Seed
$541k–$2.5M
Series A
$3M–$39M

Investment Focus

Industry

  • Biotechnology 9 (64%)
  • Manufacturing 5 (36%)
  • Chemical 3 (21%)
  • Health Care 3 (21%)
  • Life Science 3 (21%)
See all 26 industries →

Stage

  • Seed 6 (43%)
  • Series A 3 (21%)
  • Funding Round 3 (21%)
  • Pre-Seed 1 (7%)
  • Venture - Series Unknown 1 (7%)

Country

  • Germany 11 (79%)
  • Poland 1 (7%)

Team

NameTitleInvestmentsLinksEmail
Peter Kallien
Peter Kallien Managing Director and Founder
Managing Director and Founder Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
PL BioScience PL BioScience
STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade. $8.5M / Series A / Aug 08, 2024
Cultimate Foods Cultimate Foods
Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs." $2.5M / Seed / Apr 23, 2024
traceless materials traceless materials
traceless materials is offering a holistically sustainable alternative to plastics and bioplastics. With our first-of-a-kind biomaterial it’s our mission to contribute to solving global plastic pollution.Our innovative technology filed for patent allows to use food production residues to produce materials that are compostable under naturalcomposting conditions. While bio-based, our materials don’t compete with food nor cause land-use-change, don’t need hazardous additives or solvents and have up to 95% lower CO2 emissions. Our materials are neither chemically modified nor synthetically polymerized, therefore they will not fall under the EU Single Use Plastic Directive. Follow us on our journey, and become a part of the solution, not the pollution! $38.8M / Series A / Sep 25, 2023
revoltech revoltech
Developer of textile technology intended to transform the way material is made. Revoltech‘s first product is LOVR: the world's first plastic-free and 100% plant-based leather alternative made of agricultural residues. $1.1M / Pre-Seed / May 24, 2022
FibreCoat FibreCoat
FibreCoat GmbH produces thermoplastic-coated glass fibres for use in fibre composites on rented glass fibre drawing machines. Direct coating enables new process steps, lower costs and cycle times while at the same time improving technical specifications. The target markets are the automotive and consumer sectors. $3M / Oct 21, 2021
FibreCoat FibreCoat
FibreCoat GmbH produces thermoplastic-coated glass fibres for use in fibre composites on rented glass fibre drawing machines. Direct coating enables new process steps, lower costs and cycle times while at the same time improving technical specifications. The target markets are the automotive and consumer sectors. $3M / Series A / Oct 21, 2021
Actome Actome
Actome focuses on developing emulsion coupling technology for life science research and personalized medicine. Seed / Jul 01, 2021
Placeme Placeme
Placeme is a data-as-a-service solution, allowing you to predict customer behaviour and sales potential at specific address thus helping retail and fmcg to increase revenue by improving sales and marketing.And it is an easy to use online SaaS tool so everybody can use it, getting complex insights in few mouse clicks. We help to improve yourbusiness by leveraging big data and machine learning thus helping you to make better business decisions and gain customers with geotargeted ads based on people behaviour in real life.Find places with business potential - gain comprehensive knowledge about the best location for your business and potential contractors. With placeme it's very simple - just enter the address.Check potential earnings - placeme provides an access to a huge amount of data that we obtain. Based on these sources our unique machine learning algorithms are able to find a perfect place for a business with the highest earning potential.Learn consumer habits - have you ever wondered where your customers come from and how do they choose certain products and services? Placeme enables an accurate analysis of customer journey both in online and offline sales channels.Get new customers - advertising based on geolocation allows you to reach the profiled consumers who live or work in a defined area. Placeme will help you find them!Location is key to your success, we help you calculate its potential! $540.6K / Seed / May 18, 2021
traceless materials traceless materials
traceless materials is offering a holistically sustainable alternative to plastics and bioplastics. With our first-of-a-kind biomaterial it’s our mission to contribute to solving global plastic pollution.Our innovative technology filed for patent allows to use food production residues to produce materials that are compostable under naturalcomposting conditions. While bio-based, our materials don’t compete with food nor cause land-use-change, don’t need hazardous additives or solvents and have up to 95% lower CO2 emissions. Our materials are neither chemically modified nor synthetically polymerized, therefore they will not fall under the EU Single Use Plastic Directive. Follow us on our journey, and become a part of the solution, not the pollution! Seed / May 03, 2021
b.fab b.fab
B.fab specializes in the conversion of CO2 and hydrogen from renewable energy into biotechnological value chains.It utilizes formate as its central mediator to bind and store CO2 and H2 (made from water) in liquid form. The company's bioprocesses start with the feedstock formate and it uses synthetic biology to design specific pathways andto convert formate into value-added chemicals. The platform is built on anaerobic and aerobic microbial production hosts to provide flexibility in the process design and adaptation to specific product requirements. B.fab GmbH applies laboratory automation, high-throughput experimentation, and advanced bioprocess development in an agile environment to develop new bioprocesses efficiently and in a minimal time frame. It was founded in 2018 in Dortmund, Nordrhein-Westfalen. Seed / Jan 06, 2021
See all 14 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Email
Payments
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Hospitality
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Fashion
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Social
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Beauty
Enterprise
Community
Media (Entertainment)
Infrastructure
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Taiwan
Liberia
Mexico
Nigeria
Tunisia
Russian Federation
Togo
Guinea
Nepal
Sweden
Iran
Isle of Man
Madagascar
Pakistan
Zimbabwe
Zambia
Norway
Romania
Tajikistan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Malawi
Venezuela
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Canada
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
United Kingdom
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does b.value AG invest in?

b.value AG invests primarily in Biotechnology, Manufacturing and Chemical startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is b.value AG's check size?

b.value AG typically joins rounds of $541k–$2.5M at Seed and $3M–$39M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds b.value AG participates in.

How do I contact b.value AG?

Public channels for b.value AG include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at b.value AG?

The team at b.value AG includes Peter Kallien (Managing Director and Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
b.value AG b.value AG Find emails